[1]周俊明,倪艳秀,范宝超,等.非洲猪瘟病毒p30蛋白氨基酸序列分段表达及反应原性分析[J].江苏农业学报,2024,(10):1875-1881.[doi:doi:10.3969/j.issn.1000-4440.2024.10.012]
　ZHOU Junming,NI Yanxiu,FAN Baochao,et al.Expression and reactogenicity analysis of the truncated amino acid sequence of p30 protein in African swine fever virus[J].,2024,(10):1875-1881.[doi:doi:10.3969/j.issn.1000-4440.2024.10.012]
点击复制

非洲猪瘟病毒p30蛋白氨基酸序列分段表达及反应原性分析()
分享到：

江苏农业学报[ISSN:1006-6977/CN:61-1281/TN]

卷:
期数:
2024年10期
页码:
1875-1881
栏目:
畜牧兽医·水产养殖·益虫饲养
出版日期:
2024-10-30

文章信息/Info

Title:
Expression and reactogenicity analysis of the truncated amino acid sequence of p30 protein in African swine fever virus
作者:
周俊明; 倪艳秀; 范宝超; 祝昊丹; 朱雪蛟; 王丹丹; 胡屹屹; 李彬
(江苏省农业科学院兽医研究所/农业农村部兽用生物制品工程技术重点实验室,江苏南京210014)
Author(s):
ZHOU Junming; NI Yanxiu; FAN Baochao; ZHU Haodan; ZHU Xuejiao; WANG Dandan; HU Yiyi; LI Bin
(Institute of Veterinary Medicine, Jiangsu Academy of Agricultural Sciences/Key Laboratory of Veterinary Biological Engineering and Technology, Ministry of Agriculture and Rural Affairs, Nanjing 210014, China)
关键词:
非洲猪瘟病毒; p30蛋白; 氨基酸序列片段; 反应原性
Keywords:
African swine fever virus; p30 protein; amino acid sequence fragment; reactogenicity
分类号:
S852.65
DOI:
doi:10.3969/j.issn.1000-4440.2024.10.012
文献标志码:
A
摘要:
为比较非洲猪瘟病毒(African swine fever virus, ASFV)p30蛋白氨基酸序列中不同片段的反应原性,探究p30蛋白氨基酸序列中可能的抗原优势片段。本研究通过PCR、克隆技术将p30蛋白氨基酸序列中不同片段的编码基因分别插入表达质粒pET32a,经IPTG诱导、Ni柱纯化、透析后,获得p30蛋白氨基酸序列中8～101 aa片段(P-1#)、58～101 aa片段(P-2#)、101～158 aa片段(P-3#)、8～194 aa片段(P-4#),用酶联免疫吸附试验(ELISA)分析p30蛋白氨基酸序列中不同片段与p30蛋白免疫兔血清和ASFV阳性猪血清的反应原性。结果显示，上述片段均获得诱导表达及纯化,表达形式有可溶性表达(P-1#、P-3#)和包涵体表达(P-2#、P-4#)。各片段以1.0 mg/L包被时,p30免疫兔血清与p30蛋白氨基酸序列中4种片段均能发生免疫反应,ASFV阳性猪血清与P-4#、P-1#反应较佳,与P-3#反应中等,与P-2#反应最弱。综上,p30蛋白氨基酸序列中不同片段反应原性的差异为认识p30抗原优势区域提供了数据,这将有助于非洲猪瘟血清学诊断抗原的科学筛选。
Abstract:
The purpose of this study was to compare the reactogenicity of different fragments of the p30 protein amino acid sequence of African swine fever virus (ASFV), and to explore the possible antigen-dominant fragments in the p30 protein amino acid sequence. In this study, the coding genes of different fragments of p30 amino acid sequence were inserted into the expression plasmid pET32a by PCR and cloning techniques. After IPTG induction, Ni column purification and dialysis, 8-101 aa fragment (P-1#), 58-101 aa fragment (P-2#), 101-158 aa fragment (P-3#) and 8-194 aa fragment (P-4#) in the amino acid sequence of p30 protein were obtained. The reactogenicity of different fragments of p30 protein amino acid sequence with p30 protein immunized rabbit serum and ASFV positive pig serum was analyzed by enzyme linked immunosorbent assay (ELISA). The results showed that the above fragments were induced and purified. The expression forms were soluble expression (P-1#, P-3#) and inclusion body expression (P-2#, P-4#). When each fragment was coated at 1.0 mg/L, the p30 immunized rabbit serum and the four fragments in the amino acid sequence of p30 protein could react with each other. The reaction of ASFV-positive pig serum with P-4# and P-1# was better, with P-3# was moderate, and with P-2# was the weakest. In summary, the differences in the reactogenicity of different fragments in the amino acid sequence of p30 protein provide data for understanding the dominant fragments of p30 antigen, which will help the scientific screening of serological diagnostic antigens of African swine fever.

参考文献/References:

[1]BLOME S, GABRIEL C, BEER M. Pathogenesis of African swine fever in domestic pigs and European wild boar[J]. Virus Research,2013,173(1):122-130.
[2]SHI Z G, CAO L Y, LUO J C, et al. A chemiluminescent magnetic microparticle immunoassay for the detection of antibody against African swine fever virus[J]. Applied Microbiology and Biotechnology,2023,107(11):3779-3788.
[3]WU K, LIU J, WANG L, et al. Current state of global African swine fever vaccine development under the prevalence and transmission of ASF in China[J]. Vaccines(Basel),2020,8(3):531.
[4]SUN E C, ZHANG Z J, WANG Z L, et al. Emergence and prevalence of naturally occurring lower virulent African swine fever viruses in domestic pigs in China in 2020[J]. Science China Life Sciences,2021,64(5):752-765.
[5]SUN E C, HUANG L Y, ZHANG X F, et al. Genotype I African swine fever viruses emerged in domestic pigs in China and caused chronic infection[J]. Emerg Microbes Infect,2021,10(1):2183-2193.
[6]JIA N, OU Y W, PEJSAK Z, et al. Roles of African swine fever virus structural proteins in viral infection[J]. Journal of Veterinary Research,2017,61(2):135-143.
[7]XU Z Y, HU Y F, LI J B, et al. Screening and identification of the dominant antigens of the African swine fever virus[J]. Frontiers in Veterinary Science,2023,10:1175701.
[8]GMEZ-PUERTAS P, RODRGUEZ F, OVIEDO J M, et al. The African swine fever virus proteins p54 and p30 are involved in two distinct steps of virus attachment and both contribute to the antibody-mediated protective immune response[J]. Virology,1998,243(2):461-471.
[9]HBNER A, PETERSEN B, KEIL G M, et al. Efficient inhibition of African swine fever virus replication by CRISPR/Cas9 targeting of the viral p30 gene (CP204L)[J]. Scientific Report,2018,8(1):1449.
[10]ZHOU J M, NI Y X, WANG D D, et al. Development of a competitive enzyme-linked immunosorbent assay targeting the-p30 protein for detection of antibodies against African swine fever virus[J]. Viruses,2023,15(1):154.
[11]DANZETTA M L, MARENZONI M L, IANNETTI S, et al. African swine fever:lessons to learn from past eradication experiences. A systematic review[J]. Frontiers in Veterinary Science,2020,7:296.
[12]JURADO C, FERNNDEZ-CARRIN E, MUR L, et al. Why is African swine fever still present in Sardinia?[J]. Transboundary and Emerging Diseases,2018,65(2):557-566.
[13]LIBERTI R, COLABELLA C, ANZALONE L, et al. Expression of a recombinant ASFV p30 protein and production of monoclonal antibodies[J]. Open Veterinary Journal,2023,13(3):358-364.
[14]BARDERAS M G, RODRGUEZ F, GMEZ-PUERTAS P, et al. Antigenic and immunogenic properties of a chimera of two immunodominant African swine fever virus proteins[J]. Archives of Virology,2001,146(9):1681-1691.
[15]NEILAN J G, ZSAK L, LU Z, et al. Neutralizing antibodies to African swine fever virus proteins p30,p54,and p72 are not sufficient for antibody-mediated protection[J]. Virology,2004,319(2):337-342.
[16]ZHOU G J, SHI Z W, LUO J C, et al. Preparation and epitope mapping of monoclonal antibodies against African swine fever virus P30 protein[J]. Applied Microbiology and Biotechnology,2022,106(3):1199-1210.
[17]马天天,张亚楠,冯亚文,等. 非洲猪瘟病毒p30蛋白单克隆抗体的制备与鉴定[J]. 中国畜牧兽医,2023,50(7):2832-2842.
[18]PETROVAN V, YUAN F F, LI Y H, et al. Development and characterization of monoclonal antibodies against p30 protein of African swine fever virus[J]. Virus Research,2019,269:197632.
[19]MURGIA M V, MOGLER M, CERTOMA A, et al. Evaluation of an African swine fever (ASF) vaccine strategy incorporating priming with an alphavirus-expressed antigen followed by boosting with attenuated ASF virus[J]. Archives of Virology,2019,164(2):359-370.
[20]张文燕,陈立功,腾召剑,等. 基于非洲猪瘟病毒p30蛋白的间接ELISA抗体检测方法的建立[J]. 中国兽医学报,2022,42(7):1320-1326.
[21]JIN J X, BAI Y L, ZHANG Y Y, et al. Establishment and characterization of a novel indirect ELISA method based on ASFV antigenic epitope-associated recombinant protein[J]. International Joural of Biological Macromolecules,2023,253(Pt7):127311.

相似文献/References:

[1]刘蓓蓓,韦艳娜,陈蓉,等.半固体培养法制备非洲猪瘟病毒pA104R蛋白的单克隆抗体[J].江苏农业学报,2024,(04):682.[doi:doi:10.3969/j.issn.1000-4440.2024.04.012]
　LIU Bei-bei,WEI Yan-na,CHEN Rong,et al.Preparation of monoclonal antibody against pA104R protein of African swine fever virus by semi-solid culture method[J].,2024,(10):682.[doi:doi:10.3969/j.issn.1000-4440.2024.04.012]

备注/Memo

备注/Memo:
收稿日期：2023-12-11基金项目：国家重点研发计划项目(2022YFD1800601)；国家自然科学基金项目(31941013)；江苏省农业科技自主创新基金项目[CX(21)3137)]；河北省省级科技计划资助项目(21322401D)；苏北科技专项(SZ-LYG202109)作者简介：周俊明(1983-),男,江苏东台人,硕士,副研究员,主要从事动物传染病防治和诊断技术研究。(Tel) 025-84390988；(E-mail) zhoujm075@163.com通讯作者：李彬,(E-mail) libinana@126.com
更新日期/Last Update: 2024-11-21